Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge

Clinical and Vaccine Immunology

Volumn 19, Issue 11, 2012, Pages 1746-1750

  Qi, Zhizhen ^a   Zhao, Haihong ^a   Zhang, Qingwen ^a   Bi, Yujing ^b   Ren, Lingling ^a   Zhang, Xuecan ^b   Yang, Hanqing ^a   Yang, Xiaoyan ^a   Wang, Qiong ^b   Li, Cunxiang ^a   Zhou, Jiyuan ^b   Xin, Youquan ^a   Yang, Yonghai ^a   Yang, Huiying ^b   Du, Zongmin ^b   Tan, Yafang ^b   Han, Yanping ^b   Song, Yajun ^b   Zhou, Lei ^b   Zhang, Pingping ^b   Cui, Yujun ^b   Yan, Yanfeng ^b   Zhou, Dongsheng ^b   Yang, Ruifu ^b   Wang, Xiaoyi ^b   more..

^a Qinghai Institute for Endemic Disease Prevention and Control of Qinghai Province   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; PLAGUE VACCINE;

AGE; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CESAREAN SECTION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; LACTATION; MALE; MOUSE; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTA; PLAGUE; PRIORITY JOURNAL; PROGENY; YERSINIA PESTIS;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; LACTATION; MALE; MICE; MICE, INBRED BALB C; PLACENTA; PLAGUE; PLAGUE VACCINE; PREGNANCY; SURVIVAL ANALYSIS; TIME FACTORS; YERSINIA PESTIS;

EID: 84868221198     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00455-12     Document Type: Article

References (31)

1. Du Y, Rosqvist R, Forsberg A. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460. (Pubitemid 34163423)
2. Elahi S, Buchanan RM, Babiuk LA, Gerdts V. 2006. Maternal immunity provides protection against pertussis in newborn piglets. Infect. Immun. 74:2619-2627. (Pubitemid 43672970)
3. Friedlander AM, et al. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21(Suppl 2):S178-S181.
4. Gans H, et al. 2003. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21:3398-3405. (Pubitemid 36792094)
5. Gans H, et al. 2001. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J. Infect. Dis. 184:817-826. (Pubitemid 32881086)
6. Gans HA, et al. 1998. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527-532. (Pubitemid 28377671)
7. Gitlin JD, Gitlin D. 1974. Protein binding by specific receptors on human placenta, murine placenta, and suckling murine intestine in relation to protein transport across these tissues. J. Clin. Invest. 54:1155-1166.
8. Guyer R, Koshland ME, Knopf PM. 1976. Immunoglobulin binding by mouse intestinal epithelial cell receptors. J. Immunol. 117:587-593.
9. Karlyshev AV, Galyov EE, Abramov VM, Zav'yalov VP. 1992. Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett. 305:37-40.
10. Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW. 1997. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 23:167-179. (Pubitemid 27387534)
11. Mbawuike IN, Six HR, Cate TR, Couch RB. 1990. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J. Virol. 64:1370-1374. (Pubitemid 20087783)
12. Overheim KA, et al. 2005. LcrV plague vaccine with altered immunomodulatory properties. Infect. Immun. 73:5152-5159. (Pubitemid 41105674)
13. Oyedele OO, Odemuyiwa SO, Ammerlaan W, Muller CP, Adu FD. 2005. Passive immunity to measles in the breastmilk and cord blood of some Nigerian subjects. J. Trop. Pediatr. 51:45-48. (Pubitemid 40394192)
14. Perry RD, Fetherston JD. 1997. Yersinia pestis- etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
15. Qi Z, et al. 2010. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1 + rV270. Vaccine 28:1655-1660.
16. Qiu Y, et al. 2010. Comparison of immunological responses of plague vaccines F1 + rV270 and EV76 in Chinese-origin Rhesus macaque, Macaca mulatta. Scand. J. Immunol. 72:425-433.
17. Rasoamanana B, et al. 1997. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin. Diagn. Lab. Immunol. 4:587-591. (Pubitemid 27448627)
18. Reuman PD, Paganini CM, Ayoub EM, Small PA, Jr. 1983. Maternalinfant transfer of influenza-specific immunity in the mouse. J. Immunol. 130:932-936. (Pubitemid 13186331)
19. Riedel S. 2005. Plague: from natural disease to bioterrorism. Proc. (Bayl. Univ. Med. Cent.) 18:116-124.
20. Roggenkamp A, Geiger AM, Leitritz L, Kessler A, Heesemann J. 1997. Passive immunity to infection with Yersinia spp. mediated by antirecombinant V antigen is dependent on polymorphism of V antigen. Infect. Immun. 65:446-451. (Pubitemid 27053207)
21. Russell P, et al. 1995. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551-1556.
22. Saji F, Samejima Y, Kamiura S, Koyama M. 1999. Dynamics of immunoglobulins at the feto-maternal interface. Rev. Reprod. 4:81-89. (Pubitemid 29245932)
23. Shepard CW, et al. 2002. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg. Infect. Dis. 8:1124-1132. (Pubitemid 35257005)
24. Sidiropoulos D, Herrmann U, Morell A, von Muralt G, Barandun S. 1986. Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy. J. Pediatr. 109:505-508. (Pubitemid 16014284)
25. Siegrist C. 2003. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21:3406-3412. (Pubitemid 36798059)
26. Sumaya CV, Gibbs RS. 1979. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J. Infect. Dis. 140:141-146. (Pubitemid 10243083)
27. Sweet C, Bird RA, Jakeman K, Coates DM, Smith H. 1987. Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines. Immunology 60:83-89. (Pubitemid 17230144)
28. Wang T, et al. 2008. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Protein Expr. Purif. 61:7-12.
29. Wang T, et al. 2008. Cloning and expression of Yersinia pestis rV270 antigen and efficacy against Y. pestis virulent strain challenge. Lett. Biotechnol. 19:663-666.
30. Wang Z, et al. 2010. Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice. Clin. Vaccine Immunol. 17:199-201.
31. Williamson ED. 2001. Plague vaccine research and development. J. Appl. Microbiol. 91:606-608. (Pubitemid 32948382)